BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, providing promising developments across many health care and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, extra reliable choice for therapeutic use, significantly in